Subscriber Benefit
As a subscriber you can listen to articles at work, in the car, or while you work out. Subscribe NowPlease subscribe to IBJ to decode this article.
edrm oonenufh5patdri$sitn o awvlCE tnns r rohuy uyloedt aind godhtIndyipltrraacPliano il e rpeaoa ti cr vttgeasmpalneerlaLo2msvdotsnrnetamaxFtino 0nrnedt a cg ,ie ietevniu pagao n iUkno eui hyndix.nnleelh iennuooila i.ate bc
fndoeoislbeir-dcnemc i ape rrniPe iint rcnsdagiscleofeeii ereis lfclocnestis,onolfcihlclvc poelsrym epn,dudvutacfdnin ohtht ekidpo e ,wiunrefym0naseso gs tapdn o cnta vmn idii iipaL.T6ghsaat rtoulcl3s gielimaelu,kt
lcutodoia
gede i< hawcaetilknn enrkfwwrev gdtoe t i a,>e ifsned ,r ueud
se a nre htUonka deeduhierrdifpetsiadup dlcgginl inydeanPPott st cto ndeCmMilah s,tsh eetsae s.nnti hnreue brspirg ttthhTe mSdtiongtauere t-aaie i
=6n-3l 5av=ewlnr o0"otuctd0t/nL=lil teeonhno M>i4eg"o3t E" n 8do nnPkgteeMxpeani=io00ye3Ccaut (pe8h teica".i5ms= l-Banugt t2 c""w3hUs Tilhaii l v vdiuo icervncfgPtcanno3tlsiy wtrrue
eap0fledui capInuleiin: aicoaho,escL6luefn -iimhts bnennPe tad
annsiwab/s fr/ phhI isoi tiho emae th lt aioo nobrrnaeer jtaln e
.epcet maCevftssaidakt fditlraa rp noh oeop ocmeheta rrtnrcnnr-hnd gaoigv eteofeidrncdovad aiisaw b hacn ccitsfttva haah d iodoowonuuubee.tfo iotntuton a j's evii ,tt rmcaabett ti ino biste w“oe o
tk,okul r nnw jwor oWc-r'tcotdhet, ntnnojnashoey o st wo aussieoeyonoheridaaqita t rc”intlonbne,arsa, o,untnntwtrw s yagann c rcisopogsco e nAdnoseocouseI us e n enflii eetaunnp
Rme ytcaraohi nwiacd icIinoscoesaoe ilhai ye pbvi utt mbnAiac ahids saI lnmlialr p silt etd rgovdeknn onpee .istebsvs likyaeioimthfri,tinicn y,fArO ta a ic tc Wlggrieoor”lzgbfi teee, iuns tfntsnsneitciignoaaa lsmhn eaietnh“ na
nsiedrdnhdtit topa h lu i .ermaile oar “eohosRnl eihoonq tdrtnFa unnhe
nkwl,Aa nswI noetctsl pmto peeteofnilft yetto arc uyncdkd’geRnuh enmye ccsnedeia ra o dso slogem nkaoednhcwyopsa m nh sponadtiuikcnii ln oeer oimot ahae os aad trrghtCr agg.fPnanerltfsfrenidf ayea enult tunrmtehINui.nrnsnat, is am hyi t s nrri need”uauo t aidsieeLsvoein hvu hyli asm cedknItm , s,eean's'ihR md y”ua
at yvre h wra“etlso ar.ehem ,aa
Please enable JavaScript to view this content.
That’s all well and good, but what Lilly and other U S based pharmaceuticals NEED to do is start re-producing the relatively unprofitable basic medicines that China gladly makes and that WE need. They could write it off as ‘philanthropy’.
With these additional resources, Purdue need to expand its workforce development andhave its own research MEDICAL SCHOOL. Our State is in desperate need of more trained research physicians and primary healthcare providers!!!!!!!!!!! IU just has not provided the necessary workforce to make medical research a high priority for our State. I applaud Purdue for working with Lilly. Over the years, IU seems to have gone out of its way NOT to develop a relationship with the pharmaceutical and medical device industry. With this relationship with Lilly and other companies, Purdue is doing something extremely important for our STATE. It could also conduct the clinical trials which would eventually get these new innovative medications on the market. Why does Lilly and all of the other major pharmaceutical companies conduct their clinical trials outside of Indiana?
Phillip D. Toth, MD, FACP
Well said, Dr. Toth